Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer December 2018 16(6):421-428 - Subject
- Language
- ISSN
- 1558-7673